Clinical Trial Update: Vitamin D and Hereditary Haemorrhagic Telangiectasia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update investigating vitamin D for hereditary haemorrhagic telangiectasia is reported with unknown current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Haemorrhagic Telangiectasia

Snippet

Sponsor: St. Paul's Hospital, Canada | Conditions: Hereditary Haemorrhagic Telangiectasia | Phase 2 | Status: UNKNOWN